Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,905,028
+$649,585 QoQ
Shares Held
7,501
+46.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#2,399
of 4,676 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fi3 FINANCIAL ADVISORS, LLC holds $6,620,183 across 8 Drug Manufacturers - General names. JNJ ranks #1 (28.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
7,501 | $1,905,028 | |
| 2 | ABBV |
AbbVie Inc.
|
7,080 | $1,781,611 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
9,091 | $1,148,556 | |
| 4 | LLY |
ELI LILLY & Co
|
7,465 | $555,769 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,478 | $446,923 | |
| 6 | AMGN |
Amgen Inc
|
1,043 | $377,691 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,064 | $234,167 | |
| 8 | PFE |
Pfizer Inc
|
7,078 | $170,438 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,905,028 | 7,501 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,255,443 | 5,136 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $925,687 | 4,473 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $738,342 | 3,982 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $574,034 | 3,758 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $776,131 | 4,680 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $394,523 | 2,728 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $512,595 | 3,163 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $431,025 | 2,949 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $380,605 | 2,406 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $450,157 | 2,872 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $477,685 | 3,067 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $505,663 | 3,055 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $461,280 | 2,976 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $529,066 | 2,995 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $327,046 | 2,002 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $347,564 | 1,958 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $322,913 | 1,822 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $284,831 | 1,665 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $238,858 | 1,479 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $245,627 | 1,491 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $229,761 | 1,398 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||